zidovudine has been researched along with atevirdine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balani, SK; Ciccarone, TM; Condra, JH; Emini, EA; Goldman, ME; Greenlee, WJ; Kauffman, LR; MacTough, SC; Rooney, CS; Williams, TM | 1 |
| Althaus, IW; Biles, C; Busso, M; Genin, MJ; Morge, RA; Resnick, L; Reusser, F; Romero, DL; Tarpley, WG; Thomas, RC | 1 |
| Nottet, HS; Oteman, MH; Verhoef, J; Visser, MR | 1 |
| Bassiakos, Y; Demeter, LM; Fischl, M; Greisberger, C; Leedom, J; Morse, GD; Para, M; Powderly, W; Reichman, RC; Resnick, L | 1 |
| Campbell, TB; D'Aquila, RT; Eron, JJ; Kuritzkes, DR; Tarpley, WG; Young, RK | 1 |
| Been-Tiktak, AM; Borleffs, JC; Boucher, CA; de Graaf, L; de Haas, CJ; Nottet, HS; Schuurman, R; Verhoef, J | 1 |
| Bassiakos, Y; Batts, D; Cox, S; Demeter, LM; Fischl, MA; Leedom, J; Morse, GD; Para, M; Powderly, W; Reichman, RC; Resnick, L; Timpone, J | 1 |
2 trial(s) available for zidovudine and atevirdine
| Article | Year |
|---|---|
Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Safety; Time Factors; Zidovudine | 1995 |
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Sex Characteristics; Zidovudine | 2000 |
5 other study(ies) available for zidovudine and atevirdine
| Article | Year |
|---|---|
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
Topics: Animals; Antiviral Agents; Base Sequence; Biological Availability; HIV; HIV Reverse Transcriptase; HIV-1; Indoles; Macaca mulatta; Molecular Sequence Data; Molecular Structure; Reverse Transcriptase Inhibitors; Sulfoxides | 1993 |
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]pi
Topics: Antiviral Agents; Delavirdine; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 1993 |
Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
Topics: Antiviral Agents; Delavirdine; Drug Resistance, Microbial; HIV-1; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Zidovudine | 1994 |
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
Topics: Antiviral Agents; Cells, Cultured; Didanosine; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Piperazines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.
Topics: Amino Acid Sequence; Delavirdine; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Molecular Sequence Data; Monocytes; Piperazines; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine | 1997 |